Postmarket Surveillance Reform Board Gets Injection Of Device Industry Experience
This article was originally published in The Gray Sheet
Executive Summary
The appointments of three device industry veterans to the Brookings-administered, and partially FDA-funded, Planning Board is intended to expand the range of input in the next phase of development of a new National Medical Device Surveillance System.
You may also be interested in...
Negotiating Prices For Real-World Data Can Lower FDA Submission Costs, Shuren Says
A new national evaluation system for devices will provide collective bargaining power to reduce the costs of real-world data to substitute for clinical trials in company submissions.
Device Surveillance Reform Board Looks To Add Small-Firm Experience
The public-private National Medical Device Evaluation System Planning Board, first convened in 2014, is seeking nominations for new members to support the next two-year phase of development of a revamped postmarket surveillance system.
Task Force Advocates Making Registries Better Than Sum Of Their Parts
The FDA-endorsed Medical Device Registry Task Force maps out a path toward "coordinated registry networks," starting with pilot projects and 11 prioritized device categories.